| Literature DB >> 29410510 |
Elena Martín-Hernández1,2, María Elena Rodríguez-García3, Chun-An Chen4,5, Francisco Javier Cotrina-Vinagre3, Patricia Carnicero-Rodríguez3, Marcello Bellusci1, Christian P Schaaf4,5, Francisco Martínez-Azorín6,7.
Abstract
We report the clinical and biochemical findings from a patient who presented with Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS), an autosomal-dominant disorder characterized by optic atrophy, developmental delay and intellectual disability. In addition, the patient also displays hypotonia, stroke-like episodes, and complex IV deficiency of the mitochondrial respiratory chain. Whole-exome sequencing (WES) uncovered a novel heterozygous mutation in the NR2F1 gene (NM_005654:c.286A>G:p.Lys96Glu) that encodes for the COUP transcription factor 1 protein (COUP-TF1). Loss-of-function mutations in this protein have been associated with BBSOAS, and a luciferase reporter assay showed that this variant, in the zinc-finger DNA-binding domain (DBD) of COUP-TF1 protein, impairs its transcriptional activity. The additional features of this patient are more related with mitochondrial diseases that with BBSOAS, indicating a mitochondrial involvement. Finally, our data expand both the genetic and phenotypic spectrum associated with NR2F1 gene mutations.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29410510 DOI: 10.1038/s10038-017-0398-3
Source DB: PubMed Journal: J Hum Genet ISSN: 1434-5161 Impact factor: 3.172